Mr. Speaker, as the hon. member should know, our partners in the provinces and the territories are responsible for deciding which drugs are publicly reimbursed. That is why we have increased the federal transfers to the provinces and territories each year by 6%.
Our leadership and commitment to working with the provinces and territories continue to better our health care system and to make it more efficient.